Rockwell Medical (RMTI) Depreciation and Depletion (2017 - 2026)
Rockwell Medical (RMTI) posted Depreciation and Depletion of $400000.0 for Q1 2026, little changed on a QoQ basis from $400000.0 in Q4 2025, and little changed year-over-year from $400000.0 in Q1 2025.
Rockwell Medical (RMTI) Depreciation and Depletion (2017 - 2026) Analysis & Trends
Rockwell Medical's Depreciation and Depletion history runs 10 years deep, the most recent figure standing at $400000.0 for Q1 2026.
- Quarterly Depreciation and Depletion changed 0.0% year-over-year to $400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (changed 0.0% YoY) and the FY2025 annual result came in at $1.6 million, changed 0.0% from the prior year.
- Depreciation and Depletion was $400000.0 for Q1 2026 at Rockwell Medical, roughly flat from $400000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $400000.0 in Q3 2023 and bottomed at $100000.0 in Q1 2022.
- A 5-year average of $311764.7 and a median of $400000.0 in 2023 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion plunged 50.0% — and 2023, when it jumped 300.0%.
- Rockwell Medical's Depreciation and Depletion stood at $200000.0 in 2022, then jumped by 100.0% to $400000.0 in 2023, then changed by 0.0% to $400000.0 in 2024, then changed by 0.0% to $400000.0 in 2025, then changed by 0.0% to $400000.0 in 2026.
- Business Quant data shows RMTI's Depreciation and Depletion at $400000.0 in Q1 2026, $400000.0 in Q4 2025, and $400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |